Autopsy report · NCT00074295

S0310: Vaccine Therapy in Treating Patients With Stage IIIB or Stage IV Bronchoalveolar Lung Cancer

“closed due to lack of availability of vaccine”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 3 years 5 months before it stopped.
• 19 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

SWOG Cancer Research Network

Sponsor type

University, hospital or other

Conditions

Lung Cancer

Interventions

GVAX lung cancer vaccine

Participants

19

Trials that died the same way

• S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer
  “Closed due to lack of drug availability.” (69% match in meaning)
• Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma
  “Vaccine manufacturing has been suspended” (67% match in meaning)
• A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma
  “Closed due to historically slow enrollment compounded by the COVID-19 pandemic.” (64% match in meaning)
• 3D Printed Rigid Bolus Versus Silicone Bolus for Treatment of Tumors Involving the Skin: A Comparative Study
  “Closed during Covid Pandemic, and no longer supported locally” (59% match in meaning)
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
  “closed due to futility” (57% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.